![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 19, 2018 8:34:13 PM
As for CHA, I don't know what to think. They have seen a recent run of late, so possibly just taking advantage of that. CHA seems exactly like UT. Just say nothing except the token couple paragraphs in every report, then the hammer falls.
I haven't had the time to take a look into this SK treatment. Only see that they are in phase 2 trials. I still believe in our treatment, because of the male female thing. We have been at quite the disadvantage over others having 50/50 male female ratio. Others got their numbers with total males or very skewed numbers for males. We were 100% successful with males.
We truly need a partnership or a big influx of cash from somewhere other than dilution. The oncology news was big, and shows the broad scope of indications we could take a stab at. Getting the cash risk off the table would do wonders for this stock. Should have been done long ago, like many others have.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM